Will a State Street Global Stocks ETF Give You Better Returns Than a Schwab Emerging Markets Fund?
Source: The Motley Fool
SPDR Portfolio MSCI Global Stock Market ETF (SPGM) outperformed Schwab Emerging Markets Equity ETF (SCHE), delivering a 24.4% one-year total return versus 20.3% and annualized 10-year returns of 12.9% versus 8.1%. SPGM also produced a higher five-year growth result ($1,742 from $1,000 versus $1,426), although SCHE offers a lower 0.06% expense ratio, a higher 2.6% distribution yield, and more emerging-market diversification. The comparison favors SPGM for historical returns, while SCHE may better diversify portfolios with substantial U.S. equity exposure.
Analysis
This is not a clean broad-market versus emerging-market decision: SCHE is economically a concentrated Asia semiconductor/China-internet factor basket, with TSM alone likely to drive a disproportionate share of both upside and drawdown. Its apparent diversification benefit can fail precisely when it is most needed: a Taiwan geopolitical shock, global handset/AI-capex downturn, or renewed China policy pressure would simultaneously hit its largest country and sector exposures. The higher distribution yield is not a sufficient offset for this concentration risk, particularly because EM financial-sector dividends can be cyclical and FX-sensitive.
SPGM is a low-cost vehicle for maintaining the U.S. mega-cap AI trade rather than meaningfully diversifying an existing S&P 500 or Nasdaq-heavy book. Its key portfolio-level risk is multiple compression in NVDA, MSFT and AAPL: a modest reversal in the AI-capex cycle could create correlated selling across the fund despite its large holdings count. The non-obvious implication is that a rotation from U.S. growth into EM would not necessarily favor SCHE broadly; it would principally require TSM earnings resilience and a re-rating in Chinese internet, while India and smaller EM opportunities are underrepresented.
There is no standalone ETF trade from this routine comparison. Over the next 1-3 months, relative performance should be governed by USD direction, China stimulus credibility, TSM guidance, and AI infrastructure spending—not fee differences or trailing returns. Over 6-18 months, SCHE can outperform if global manufacturing recovers, the dollar weakens, and China risk premia compress; the thesis is falsified by TSM cutting utilization/capex expectations, renewed Taiwan risk escalation, or a sustained strengthening in the dollar.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.28
Ticker Sentiment
Key Decisions for Investors
- Do not add SPGM as a diversifier to portfolios already long SPY, QQQ, NVDA, MSFT or AAPL; treat it as incremental U.S. mega-cap growth exposure and cap aggregate single-factor exposure accordingly.
- For a tactical EM allocation, use SCHE only with an explicit TSM/Taiwan risk budget. Initiate after TSM’s next guidance confirms sustained AI/HPC demand and China policy support improves; exit or hedge if TSM cuts revenue outlook or Taiwan-risk headlines widen the TSM-versus-SOX valuation discount materially.
- Prefer a conditional pair trade—long SCHE / short SPGM—only after a sustained USD rollover and evidence of Chinese credit/stimulus transmission. Target a 3-6 month rotation window; risk is renewed U.S. AI earnings upside or dollar strength, which would favor SPGM’s concentrated U.S. technology exposure.
- For direct exposure to the most investable SCHE driver, monitor TSM rather than relying on the ETF: long TSM can offer cleaner upside if AI foundry demand exceeds expectations, while downside must be sized for geopolitical gap risk that cannot be reliably stopped out.
More News
- AI funding fears rattle Wall Street. Here's how we're adjusting our portfolio
- Nvidia's role as AI financier faces first big test as neoclouds take market hit
- Goldman says these top tech stocks have plenty of upside ahead of earnings
- Spotify Earnings: A Miss, But Long-Term Potential Remains
- The AI graveyard: a running list of projects and startups that didn’t make it
- Is Berkshire Bending the Rules With Bending Spoons?
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- Can Hedge Funds Use ChatGPT? A Control Framework
- Palantir (PLTR) Q4 2025 Earnings: 70% Revenue Growth, Then an 11% Single-Day Crash